ARRY Financial Facts
Interest expense: -2.98MLoss from operations: -24M
See Full Income Statement
Deferred rent: 596K
Total current liabilities: 64.21M
See Full Balance Sheet
Array BioPharma, Inc. (ARRY) Earnings
|
Expand Research on ARRY
| Next EPS Date | 5/7/24 | EPS Growth Rate | -112.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +261.7% | Revenue Growth Rate | -62.5% |
| Average % Move 1-Wk after EPS | +3.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/24 | Q124 | N/A | -$0.03 | N/A | N/A | $141.47M | = | N/A | N/A | ||
| 2/27/24 | Q423 | $0.21 | $0.11 | +$0.10 | $341.6M | $315.25M | = |  | | Details | |
| 11/7/23 | Q323 | $0.21 | $0.13 | +$0.08 | $350.4M | $374.33M | = | | | Details | |
| 8/8/23 | Q223 | $0.47 | $0.18 | +$0.29 | $507.7M | $449.11M | = | | | Details | |
| 5/9/23 | Q123 | $0.25 | $0.03 | +$0.22 | $376.8M | $322.8M | = | | | Details | |
| 3/15/23 | Q422 | N/A | $0.10 | N/A | N/A | $360.65M | = | N/A | N/A | ||
| 3/21/23 | Q422 | $0.10 | $0.10 | $0.00 | $402.1M | $360.65M | = | | | Details | |
11/8/22  |
Q322 | $0.18 | $0.09 | +$0.09 | $515M | $395.92M | = | | | Details |
